Yet, TSB must ask the $200 million dollar quesiton; How does a company grow as quickly as Globus Medical has over the last three years? Let me count the ways.
Do any of our readers believe that this is a "squeaky clean" company? Originally when this company was started, David Paul committed as many mortal sins as an individual can, witnessed by the litigation between Synthes and Globus. In my old neighborhood, this type of behavior would have been handled by breaking some legs. I guess Hansjoerg Wyss is getting old! How many surgeon investors are there? Isn't this company similar in its business model to K2M Spine? How many creative consulting agreements does this company have on the books? 20? 30? 50? How many start-up practices has this company subsidized?
Regardless whether our readers agree with the strategy and tactics employed by the Golden Child, you can't argue with success! As Globus continues to increases revenue, TSB believes that the only strategy left for this company is to take it public. Unfortunately, this is not the year to do it. As the economy continues to exhibit a rebound in 2010, next year may be the time to hop on the Acela and pay a visit to Goldman Sachs. I mean if you are going to continue making a splash who else should underwrite the initial public offering. TSB wants to know what our readers think?